Literature DB >> 19048299

A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.

Monica Terenziani1, Michele Sardella, Beatrice Gamba, Maria Adele Testi, Filippo Spreafico, Gianluigi Ardissino, Fausto Fedeli, Franca Fossati-Bellani, Paolo Radice, Daniela Perotti.   

Abstract

The WT1 gene plays a crucial role in urogenital and gonadal development. Germline WT1 alterations have been described in a wide spectrum of pathological conditions, including kidney diseases, genital abnormalities and Wilms tumor (WT), frequently occurring in combination. We report on a novel WT1 nonsense mutation (c.1105C>T), introducing a premature stop codon in exon 8 (p.Q369X), in a young XY male patient who presented with bilateral cryptorchidism, nystagmus, mild proteinuria and WT, but no sign of severe nephropathy. Although the majority of congenital urogenital abnormalities are not due to constitutional defects of the WT1 gene, our findings provide a rational for considering WT1 mutational analysis as one of the screening options in newborns with congenital defects of the urogenital tract due to the associated high risk of WT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048299     DOI: 10.1007/s00467-008-1056-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  41 in total

1.  Familial Wilms' tumor associated with a WT1 zinc finger mutation.

Authors:  C Kaplinsky; M Ghahremani; Y Frishberg; G Rechavi; J Pelletier
Journal:  Genomics       Date:  1996-12-15       Impact factor: 5.736

2.  WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis.

Authors:  Katsuyoshi Kanemoto; Kenji Ishikura; Daisuke Ariyasu; Yuko Hamasaki; Hiroshi Hataya; Yukihiro Hasegawa; Masahiro Ikeda
Journal:  Pediatr Nephrol       Date:  2006-10-24       Impact factor: 3.714

Review 3.  A clinical overview of WT1 gene mutations.

Authors:  M Little; C Wells
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

4.  Combination of WAGR and Potocki-Shaffer contiguous deletion syndromes in a patient with an 11p11.2-p14 deletion.

Authors:  Dominique Brémond-Gignac; John A Crolla; Henri Copin; Agnès Guichet; Dominique Bonneau; Laurence Taine; Didier Lacombe; Clarisse Baumann; Brigitte Benzacken; Alain Verloes
Journal:  Eur J Hum Genet       Date:  2005-04       Impact factor: 4.246

Review 5.  A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.

Authors:  Rosemary W Heathcott; Ian M Morison; Marie Claire Gubler; Robin Corbett; Anthony E Reeve
Journal:  Hum Mutat       Date:  2002-04       Impact factor: 4.878

6.  Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.

Authors:  C Jeanpierre; E Denamur; I Henry; M O Cabanis; S Luce; A Cécille; J Elion; M Peuchmaur; C Loirat; P Niaudet; M C Gubler; C Junien
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

7.  Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.

Authors:  P N Baird; A Santos; N Groves; L Jadresic; J K Cowell
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

8.  A novel mutation of WT1 exon 9 in a patient with Denys-Drash syndrome and pyloric stenosis.

Authors:  Min Hu; Jonathon Craig; Neville Howard; Alex Kan; Jeffrey Chaitow; Dianne Little; Stephen I Alexander
Journal:  Pediatr Nephrol       Date:  2004-07-28       Impact factor: 3.714

9.  Mutational screening of the Wilms's tumour gene, WT1, in males with genital abnormalities.

Authors:  P A Clarkson; H R Davies; D M Williams; R Chaudhary; I A Hughes; M N Patterson
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

10.  WT1 mutations in Meacham syndrome suggest a coelomic mesothelial origin of the cardiac and diaphragmatic malformations.

Authors:  Mohnish Suri; Peter Kelehan; David O'neill; Shantala Vadeyar; Judith Grant; S Faisal Ahmed; John Tolmie; Emma McCann; Wayne Lam; Shirley Smith; David Fitzpatrick; Nicholas D Hastie; William Reardon
Journal:  Am J Med Genet A       Date:  2007-10-01       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.